Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin Apotheke
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
Wiener Medizinische Wochenschrift
Erschienen in: Wiener Medizinische Wochenschrift 3-4/2014

01.02.2014 | main topic

Pancreatic pain

verfasst von: Hana Nechutova, MD, PhD, Prof. Petr Dite, MD, DSc, Prof. Marketa Hermanova, MD, PhD, Ivo Novotny, MD, CSc, Ass. Prof. Arnost Martinek, CSc, Pavel Klvana, MD, Bohumil Kianicka, MD, PhD, Prof. Miroslav Soucek, MD, DSc

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 3-4/2014

Einloggen, um Zugang zu erhalten

Summary

Pain is a common symptom of many diseases. Recently, the pain has been classified and analyzed exactly. Its particular components/types are described to the maximum of their depths and details. That is why each particular pain present in a specific disease (pancreatopathies included) has to be treated according to the presence of the specific type of pain. In diseases of pancreas, there are nociceptive, neuropathic, and inflammatory components of pain participating, frequently. Especially long-lasting, not well-controlled pain sets off the process of neuromodulation. The recent pioneering applications/administrations of various neuromodulatory therapeutic approaches represent the promising discoveries for the treatment of long-term, severe, drug-resistant pain syndromes, including chronic pancreatitis. In this article, we summarized the characteristics of pain, the therapeutic strategy, and algorithms of analgesic treatment (in general and applied for pancreatopathies), including new therapeutic trends and approaches.
Vorheriger Artikel An update on pancreatic pathophysiology (Do we have to rewrite pancreatic pathophysiology?)
Nächster Artikel Clinical approach to the patient with a solid pancreatic mass
Literatur
1.
Mantyselka P, et al. Pain as a reason to visit the doctor: a study in Finnish primary health care. Pain. 2001;89:175–80.PubMedCrossRef
2.
Cordell WH, Keene KK, Giles BK, Jones JB, Jones JH, Brizendine EJ. The high prevalence of pain in emergency medical care. Am J Emerg Med. 2002;20(3):165–9.PubMedCrossRef
3.
Hasselström J, Liu-Palmgren J, Rasjö-Wrååk G. Prevalence of pain in general practice. Eur J Pain. 2002;6(5):375–85.PubMedCrossRef
4.
Abu-Saad Huijer H. Chronic pain: a review. J Med Liban. 2010;58(1):21–7.PubMed
5.
Bonica JJ, et al. Bonica’s management of pain. Philadelphia: Lippincott Williams & Wilkins; 2001. pp. 3–16.
6.
International Association for the Study of Pain. Pain definitions [cited 10 Sep 2011]. Derived from Bonica JJ. The need of a taxonomy. Pain. 1979;6(3):247–8.
7.
Goroszeniuk T, Khan R. Permanent percutaneous splanchnic nerve neuromodulation for management of pain due to chronic pancreatitis: a case report. Neuromodulation. 2011 May-Jun;14(3):253–7.PubMedCrossRef
8.
Felipe F, Kimberly P, Deborah D, Xiaoen W, Robert L, Steven DF, Alvaro PL. Clinical effects and brain metabolic correlates in noninvasive cortical neuromodulation for visceral pain. Eur J Pain. 2011 Jan;15(1):53–60.
9.
Felipe F, Alvaro PL, Steven DF. Pain in chronic pancreatitis: a salutogenic mechanism or a maladaptive brain response? Pancreatology. 2007 Oct.;7(5–6):411–22.
10.
Christianson JA, Bielefeldt K, Altier C, Cenac N, Davis BM, Gebhart GF, Karin WH, Marian K, Alan R, Brad U. Development, plasticity and modulation of visceral afferents. Brain Res Rev. 2009 April;60(1):171–86.
11.
Merskey H, Bogduk N. Classification of Chronic Pain. 2nd ed. Seattle: International Association for the Study of Pain; 1994. p. 3, 4. ISBN 0-931092-05-1.
12.
Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011 March;152(3 Suppl.):2–15.
13.
14.
15.
16.
Schmidt BL, Hamamoto DT, Simone DA, Wilcox GL. Mechanism of cancer pain. Mol Interv. 2010 June;10(3):164–78.
17.
Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009 Sep;10(9):895–926.PubMedCentralPubMedCrossRef
18.
Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011 March;152(3 Suppl.):2–15.
19.
Davis MP. Recent advances in the treatment of pain. F1000 Med Rep. 2010;2:63.
20.
Perron V, Schonwetter RS. Assessment and management of pain in palliative care patients. Cancer Control. 2001;8(1):15–24.
21.
Demir IE, Friess H, Ceyhan GO. Nerve-cancer interactions in the stromal biology of pancreatic cancer. Front Physiol. 2012;3:97.
22.
23.
Dite P, Stary K, Novotny I, et al. Incidence of chronic pancreatitis in the Czech Republic. Eur J Gastroenterol Hepatol. 2001,13(6):249–50.
24.
Jup J, Fine D, Johnson CD. The epidemiology and socioeconomic impact of chronic pancreatitis. Best Pract Res Clin Gastroenterol. 2010;24:219–31.
25.
Lankisch PG, Lembcke B. Why is chronic pancreatitis so difficult to detect? Key clinical aspects for an early diagnosis. In: Domínguez-Muñoz JE, Malfertheiner P, editors. Clinical pancreatology: for practising gastroenterologists and surgeons. Oxford: Blackwell Publishing Ltd; 2007. doi:10.1002/9780470987506.ch27.
26.
Fries H, Zhu ZW, diMola FF, et al. Nerve growth factor and its affinity receptor in chronic pancreatitis. Ann Surg. 1999;230:615–24.
27.
Demir IE, Tieftrunk E, Maak M, Friess H, Ceyhan GO. Pain mechanisms in chronic pancreatitis: of a master and his fire. Langenbecks Arch Surg. 2011 Feb;396(2):151–60.
28.
Ceyhan GO, Demir IE, Rauch U, Bergmann F, Müller MW, Büchler MW, Friess H, Schäfer K-H. Pancreatic neuropathy results in “Neural Remodeling” and altered pancreatic innervation in chronic pancreatitis and pancreatic cancer. Am J Gastroenterol. 2009;104:2555–65.
29.
Lenz J, Karasek P, Jarkovsky J, Muckova K, Dite P, Kala Z, Veselska R, Hermanova M. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion. J Gastrointestin Liver Dis. 2011 Dec;20(4):389–96.PubMed
30.
Warshaw AL, Banks PA, Fernandez-Del Castillo C. AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology. 1998;115:765–6.PubMedCrossRef
31.
Strum WB. Abstinence in alcoholic chronic pancreatitis. Effect on pain and outcome. J Clin Gastroenterol. 1995 Jan;20(1):37–41.
32.
Mossner J, Keim V, Niederau C, et al. Guidelines for therapy of chronic pancreatitis. Consensus Conference of the German Society of Digestive and Metabolic Diseases. Halle 21–23 November 1996. Z Gastroenterol. 1998;36:359–67.
33.
Wilder-Smith CH, Hil L, Osler W, et al. Effect of tramadol and morfine on pair and gastrointestinal function in patients with chronic pancreatitis. Dig Dis Sci. 1999;44:1107–16.CrossRef
34.
Olesen S, Bouwense SAW, Wilder-Smith OHG, et al. Pregabalin reduces pain in patients with chronic pancreatitis in a randomized controlled trial. Gastroenterology. 2011;141:536–43.
35.
Drewes AM, Kraup AL, Detrlefsen S, et al. Pain in chronic pancreatitis: the role of neuropathic pain mechanisms. Gut. 2008;57:1616–27.CrossRef
36.
Uden S, Bilton D, Nathan I, et al. Antioxidant therapy for reccurent pancreatitis-placebo controlled trial. Aliment Pharmacol Ther. 1990;4:357–71.CrossRef
37.
Kirk GR, White JS, McKie I, et al. Combined antioxidant therapy reduces pain and improves quality of life in chronic pancreatitis. Gastrointest Surg. 2006;10:499–503.CrossRef
38.
Moesnner J, Secknus R, Meyer J, et al. Treatment of pain with pancreatic extracts in chronic pancreatitis: results of prospective placebo-controlled multicenter trial. Digestion. 1992;53:54–66.CrossRef
39.
Malesci A, Gaia E, Fioretta A, et al. No effect of long-term treatment with pancreatic extract on recurrent abdominal pain in patients with chronic pancreatitis. Scand J Gastroenterol. 1995;30:392–8.CrossRef
40.
Isaksson G, Ihse I. Pain reduction by an oral pancreatic enzyme preparation in chronic pancreatitis. Dig Dis Sci. 1983;28:97–102.CrossRef
41.
Halgreen H, Pederson NT, Worning H, et al. Symptomatic effect of pancreatic enzyme therapy in patients with chronic pancreatitis. Scand J Gastroent.1986;21:104–8.
42.
Wistead NS, Wilcox CM. Clinical trial sof pancreatic enzyme replacement for painful chronic pancreatitis-a review. Pancreatology. 2009;9:344–50.CrossRef
43.
Walkowiak J, Witmanowski H, Strzykala K, et al. Inhibition of endogenous pancreatic enzyme secretion by oral pancreatic enzyme treatment. Eur J Clin Invest. 2003;33:65–9.
44.
Dumonceau JM, Delhaye M, Tringali A, et al. Endoscopic treatment of chronic pancreatitis. Endoscopy. 2012;44(8):784–96.CrossRef
45.
Anderson DK, Frea CF. The evolution of surgical treatment of chronic pancreatitis. Ann Surg. 2010;251:18–32.
46.
Nguyen-Tang T, Dumonceau JM. Endoscopic treatment of chronic pankreatitis, timing, durativ and type of intervention. Best Pract Res Clin Gastroenterol. 2010;24:281–98.
47.
Costamagna, G., Tringali S. Endoscopic treatment of pain in chronic pancreatitis. Clinical Pancreatology for Practising Gastroenterologists and Surgeons. Blackwell; 2005. pp. 280–7.
48.
Dite P, Ruzicka M, Zboril Vl, Novotny I. A prospective, randomized trial comparing endoscopic and surgical therapy for chronic pancreatitis. Endoscopy. 2003;35:553–8.
49.
Cahen DL, Gouma D, Nio Y, et al. Endoscopic versus surgical drainage of pancreatic duct in chronic pankreatitis. N Engl J Med. 2007;356:676–84.
50.
Kahl S, Zimmermann S, Genz I. Risk factor for failure of endoscopic stenting of biliary strictures in chronic pancreatitis: a prospective follow-up study. Am J Gastroenterol. 2003;98:2448–53.CrossRef
51.
Metadaten
Titel
Pancreatic pain
verfasst von
Hana Nechutova, MD, PhD
Prof. Petr Dite, MD, DSc
Prof. Marketa Hermanova, MD, PhD
Ivo Novotny, MD, CSc
Ass. Prof. Arnost Martinek, CSc
Pavel Klvana, MD
Bohumil Kianicka, MD, PhD
Prof. Miroslav Soucek, MD, DSc
Publikationsdatum
01.02.2014
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 3-4/2014
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-014-0265-1

Weitere Artikel der Ausgabe 3-4/2014

Wiener Medizinische Wochenschrift 3-4/2014 Zur Ausgabe

main topic

Clinical approach to the patient with a solid pancreatic mass

main topic

Approach to cystic lesions of the pancreas

editorial

Pancreatic diseases

main topic

An update on pancreatic pathophysiology (Do we have to rewrite pancreatic pathophysiology?)

main topic

A case of obstructive jaundice due to autoimmune pancreatitis and a review of the literature